| Arginine vasopressin induces ferroptosis to promote heart failure via activation of the V1aR/CaN/NFATC3 pathway. | Arginine vasopressin induces ferroptosis to promote heart failure via activation of the V1aR/CaN/NFATC3 pathway.
Wu Z, Jiang H, Yin Q, Zhang Z, Chen X. | 04/3/2024 |
| Zonulin and copeptin relation to some metabolic markers in school-aged obese children. | Zonulin and copeptin relation to some metabolic markers in school-aged obese children.
El-Raufe El-Masry SA, Mahmoud RA, Hassan NE, Aly MM, Abdallah HR, Hamdy S, Megahed S, Elalfy DY., Free PMC Article | 02/26/2024 |
| Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET. | Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET.
Fähndrich S, Herr C, Teuteberg S, Alter P, Söhler S, Soriano D, Classen J, Adams J, Weinhold V, Watz H, Waschki B, Zeller T, Eichenlaub M, Trudzinski FC, Michels JD, Omlor A, Seiler F, Moneke I, Biertz F, Stolz D, Welte T, Kauczor HU, Kahnert K, Jörres RA, Vogelmeier CF, Bals R, German COSYCONET Cohort., Free PMC Article | 02/5/2024 |
| Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus. | Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus.
Szczepanska-Sadowska E., Free PMC Article | 02/2/2024 |
| Testing for Arginine Vasopressin Deficiency. | Testing for Arginine Vasopressin Deficiency.
Newell-Price J. | 11/21/2023 |
| The association of copeptin with metabolic risk markers is modified by region of origin. | The association of copeptin with metabolic risk markers is modified by region of origin.
Franzén A, Pikkemaat M, Melander O, Bennet L, Enhörning S., Free PMC Article | 11/14/2023 |
| Copeptin analysis in endocrine disorders. | Copeptin analysis in endocrine disorders.
Moodley N., Free PMC Article | 10/30/2023 |
| Short-term association between outdoor temperature and the hydration-marker copeptin: a pooled analysis in five cohorts. | Short-term association between outdoor temperature and the hydration-marker copeptin: a pooled analysis in five cohorts.
Timpka S, Melander O, Engström G, Elmståhl S, Nilsson PM, Lind L, Pihlsgård M, Enhörning S., Free PMC Article | 10/4/2023 |
| Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST-Elevation Myocardial Infarction. | Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST-Elevation Myocardial Infarction.
Al-Atta A, Spray L, Mohammed A, Shmeleva E, Spyridopoulos I., Free PMC Article | 09/22/2023 |
| Stimulatory effects of vasopressin on progesterone production and BMP signaling by ovarian granulosa cells. | Stimulatory effects of vasopressin on progesterone production and BMP signaling by ovarian granulosa cells.
Yamamoto K, Nakano Y, Iwata N, Soejima Y, Suyama A, Hasegawa T, Otsuka F. | 06/7/2023 |
| [Oxytocin and vasopressin: sexual differences and clinical implications]. | [Oxytocin and vasopressin: sexual differences and clinical implications].
Mondragón-Ceballos R, Barrios-De Tomasi J, Hernández-López LE., Free PMC Article | 05/23/2023 |
| The Role of Oxytocin and Vasopressin in Drug-Induced Reward-Implications for Social and Non-Social Factors. | The Role of Oxytocin and Vasopressin in Drug-Induced Reward-Implications for Social and Non-Social Factors.
Wronikowska-Denysiuk O, Mrozek W, Budzyńska B., Free PMC Article | 04/1/2023 |
| Serum Copeptin in Cardiooncology Practice: Review of Pathophysiological and Clinical Implications. | Serum Copeptin in Cardiooncology Practice: Review of Pathophysiological and Clinical Implications.
Yalta K, Yetkin E, Yalta T., Free PMC Article | 03/10/2023 |
| Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome. | Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.
Oztan O, Zyga O, Stafford DEJ, Parker KJ., Free PMC Article | 11/12/2022 |
| Requirement of Na+/H+ Exchanger NHE1 for Vasopressin-Induced Osteogenic Signaling and Calcification in Human Aortic Smooth Muscle Cells. | Requirement of Na+/H+ Exchanger NHE1 for Vasopressin-Induced Osteogenic Signaling and Calcification in Human Aortic Smooth Muscle Cells.
Zhu X, Ma K, Zhou K, Pan X, Liu J, Nürnberg B, Alesutan I, Völkl J, Lang F. | 06/25/2022 |
| Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study. | Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.
Atila C, Gaisl O, Vogt DR, Werlen L, Szinnai G, Christ-Crain M. | 06/11/2022 |
| Changed serum levels of CD62E(+), angiotensin II and copeptin in patients with chronic insomnia disorder: a link between insomnia and stroke? | Changed serum levels of CD62E(+), angiotensin II and copeptin in patients with chronic insomnia disorder: a link between insomnia and stroke?
Chen JT, Zhang P, Kong XY, Ge YJ, Li XY, Yang S, He S, Chen GH. | 05/7/2022 |
| Biomarkers-in-Cardiology 8 RE-VISITED-Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome-A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial. | Biomarkers-in-Cardiology 8 RE-VISITED-Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome-A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial.
Giannitsis E, Garfias-Veitl T, Slagman A, Searle J, Müller C, Blankenberg S, von Haehling S, Katus HA, Hamm CW, Huber K, Vollert JO, Möckel M., Free PMC Article | 02/26/2022 |
| Exploring immunoreactivity of TTF-1 and AVP in hypothalamic hamartoma. | Exploring immunoreactivity of TTF-1 and AVP in hypothalamic hamartoma.
Rao S, Sunitha K, Lanka V, Kulanthaivelu K, Arivazhagan A, Chowdary R, Raghavendra K, Rao R, Nandeesh BN, Bharath RD, Saini J, Sinha S, Santosh V, Yasha TC, Rajeswaran J, Malla BR, Mahadevan A. | 02/5/2022 |
| Cardiac Rehabilitation with Targeted Intensity Improves Cardiopulmonary Functions Accompanying with Reduced Copeptin Level in Patients with Coronary Artery Disease. | Cardiac Rehabilitation with Targeted Intensity Improves Cardiopulmonary Functions Accompanying with Reduced Copeptin Level in Patients with Coronary Artery Disease.
Cao RY, Zheng H, Hong Y, Zheng Y, Ding Y, Zhao L, Li H, Li Q, Yuan W, Liu S, Wang L, Yang J. | 01/8/2022 |
| Postnatal AVP treatments prevent social deficit in adolescence of valproic acid-induced rat autism model. | Postnatal AVP treatments prevent social deficit in adolescence of valproic acid-induced rat autism model.
Wu J, Dai YC, Lan XY, Zhang HF, Bai SZ, Hu Y, Han SP, Han JS, Zhang R. | 01/1/2022 |
| Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene. | Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene.
Alvelos MI, Francisco Â, Gomes L, Paiva I, Melo M, Marques P, Gama-de-Sousa S, Carreiro S, Quintela T, Gonçalves I, Lemos MC. | 12/4/2021 |
| Vasopressin and copeptin release during sepsis and septic shock. | Vasopressin and copeptin release during sepsis and septic shock.
Gomes DA, de Almeida Beltrão RL, de Oliveira Junior FM, da Silva Junior JC, de Arruda EPC, Lira EC, da Rocha MJA. | 12/4/2021 |
| The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes. | The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes.
Hartl L, Jachs M, Desbalmes C, Schaufler D, Simbrunner B, Paternostro R, Schwabl P, Bauer DJM, Semmler G, Scheiner B, Bucsics T, Eigenbauer E, Marculescu R, Szekeres T, Peck-Radosavljevic M, Kastl S, Trauner M, Mandorfer M, Reiberger T., Free PMC Article | 12/4/2021 |
| Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea-a prospective intervention study. | Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea-a prospective intervention study.
Karakioulaki M, Grendelmeier P, Strobel W, Schmid T, Jahn K, Grize L, Tamm M, Stolz D., Free PMC Article | 11/27/2021 |